Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study to Evaluate Safety, Efficacy of Botulinum Toxin Type A in Patients With Cervical Dystonia

NCT00564681 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT00564681
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00564681 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study to Evaluate Safety, Efficacy of Botulinum Toxin Type A in Patients With Cervical Dystonia
Lead sponsor
Allergan
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2007
Completion date
December 31, 2009
Enrollment
242 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

cervical dystonia